Replication Medical Inc
Biotechnology, 100 Jersey Ave, New Brunswick, New Jersey, 08901, United States, 11-50 Employees
Who is REPLICATION MEDICAL INC
Replication Medical develops and sells medical devices based on a novel hydrogel platform technology for degenerative conditions in spine, orthopedics, and neuro surgeries. It sells GelSt...
Read More
-
Headquarters: 100 Jersey Ave, New Brunswick, New Jersey, 08901, United States
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
Industry: Biotechnology
SIC Code: 5047
Does something look wrong? Fix it. | View contact records from REPLICATION MEDICAL INC
Replication Medical Inc Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Replication Medical Inc
Answer: Replication Medical Inc's headquarters are located at 100 Jersey Ave, New Brunswick, New Jersey, 08901, United States
Answer: Replication Medical Inc's official website is https://replicationmedical.com
Answer: Replication Medical Inc's revenue is $1 Million to $5 Million
Answer: Replication Medical Inc's SIC: 5047
Answer: Replication Medical Inc has 11-50 employees
Answer: Replication Medical Inc is in Biotechnology
Answer: Replication Medical Inc contact info: Phone number: Website: https://replicationmedical.com
Answer: Replication Medical develops and sells medical devices based on a novel hydrogel platform technology for degenerative conditions in spine, orthopedics, and neuro surgeries. It sells GelStix Nucleus Augmentation implant in Europe for treating lower back pain associated with degenerative disc disease and is currently planning the US FDA clinical trial of GelStix for approval to sell GelStix in the US. IN the US it also sells EnGuard Vessel Guard, a protective cover for spinal blood vessels in anterior fusion and total disc procedures, and GelFix Interspinous Spacer in Europe, a one piece posterior spinal distraction implant. Replication Medical has hired new management and is accelerating GelStix sales commercialization in Europe and planning the GelStix's US clinical trial for approval in the US.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month